Nephros (NEPH) Cash from Investing Activities (2010 - 2022)
Nephros (NEPH) recorded quarterly Cash from Investing Activities of -$103000.0 in Q2 2022, down 202.94% quarter-over-quarter from -$34000.0 in Q1 2022.
Nephros (NEPH) Cash from Investing Activities (2010 - 2022) Analysis & Trends
Nephros' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$103000.0 for Q2 2022.
- In Q2 2022, Cash from Investing Activities changed N/A year-over-year to -$103000.0; the TTM figure through Sep 2024 stood at -$103000.0 (changed N/A YoY), while the FY2024 annual figure was -$50000.0, up 33.33% from the prior year.
- Cash from Investing Activities was -$103000.0 for Q2 2022 at Nephros, down from -$34000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$13000.0 in Q3 2020 to a low of -$137000.0 in Q1 2019.
- Historically, Cash from Investing Activities has averaged -$55142.9 across 4 years, with a median of -$34000.0 in 2022.
- The sharpest annual moves came in 2020 and 2021: Cash from Investing Activities increased 7.14% in 2020, then tumbled 376.92% in 2021.
- A 4-year view of Cash from Investing Activities shows it stood at -$14000.0 in 2019, then rose by 7.14% to -$13000.0 in 2020, then sank by 376.92% to -$62000.0 in 2021, then slumped by 66.13% to -$103000.0 in 2022.
- The last three Cash from Investing Activities figures came in at -$103000.0 (Q2 2022), -$34000.0 (Q1 2022), and -$62000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -103,000.00 |
| Jun 30, 2022 | -103,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -26,000.00 |
| Mar 31, 2016 | -26,000.00 |